title: Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.
authors.affiliation: Gynaecological Oncology Department, University of Turin, Italy. nbiglia@mauriziano.it
authors.forename: N
authors.initials: N
authors.lastname: Biglia
authors.forename: L
authors.initials: L
authors.lastname: Mariani
authors.forename: R
authors.initials: R
authors.lastname: Ponzone
authors.forename: P
authors.initials: P
authors.lastname: Sismondi
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics* / Q000517:prevention & control*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics / Q000517:prevention & control; D010052:Ovariectomy
chemical_list: D003278:Contraceptives, Oral, Hormonal